KRT20 overexpression is frequently found in pancreatic tumor tissues and correlates with poor prognosis (Schmitz-Winnenthal et al., 2006), suggesting a biological basis for their high levels in the cEVs of PDAC patients. This evidence concerns the gene KRT20 and pancreatic neoplasm.